Alzheimer’s Drug Discovery Foundation (ADDF): Cohorts for Alzheimer’s Prevention Action

(Proposal due 5.3, LOI 2 weeks prior)
ADDF is interested in funding cross-cohort pooled analyses of actionable interventions to potentially protect against cognitive aging, Alzheimer’s disease, and related dementias. Outcomes of interest include cognition (neuropsychologic testing), diagnosis of dementia or mild cognitive impairment, and relevant neurologic biomarkers. Variables of interest include drugs used to manage other health conditions, natural products, dietary supplements, nutrition and specific dietary choices, and biomarkers that can indicate these choices. Successful applications will incorporate data from 5 or more cohorts. Cohorts participating in CAPA are described. Full applications should include a letter of support or proof of access to data for each cohort intended for inclusion. Funding: up to $100K per project.)
http://www.alzdiscovery.org/research-and-grants/request-for-proposal